Efficacy of a 3-day, low-dose treatment with 5-azacytidine followed by donor lymphocyte infusions in older patients with acute myeloid leukemia or chronic myelomonocytic leukemia relapsed after allografting

A novel effect of DNA methyltransferase and histone deacetylase inhibitors : NFκB inhibition in malignant myeloblasts

(2010) Claire Fabre et al.   CELL CYCLE

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

(2009) Pierre Fenaux et al.   LANCET ONCOLOGY

The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells

(2009) C Flotho et al.   LEUKEMIA

Donor lymphocyte infusions for acute myeloid leukaemia

(2008) Robert J. Soiffer   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

A fludarabine, thiotepa reduced toxicity conditioning regimen designed specifically for allogeneic second haematopoietic cell transplantation after failure of previous autologous or allogeneic transplantation

(2008) C Grüllich et al.   BONE MARROW TRANSPLANTATION

Long-term lymphoid-restricted split chimerism after myeloablative allogeneic BMT for bcr-abl+ ALL

(2008) A Spyridonidis et al.   BONE MARROW TRANSPLANTATION

Hypomethylation and apoptosis in 5-azacytidine–treated myeloid cells

(2008) Rasheed Khan et al.   EXPERIMENTAL HEMATOLOGY